Can we cure 50% of all multiple myeloma patients in the next five years?
The biology of the plasma cell and drug targets in multiple myeloma
How to diagnose smouldering myeloma
What’s next for rare myelomas?
The importance of anti-CD38 monoclonal antibodies for multiple myeloma